These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


132 related items for PubMed ID: 16246564

  • 1. Biological variables and prognosis of DCIS.
    van de Vijver MJ.
    Breast; 2005 Dec; 14(6):509-19. PubMed ID: 16246564
    [Abstract] [Full Text] [Related]

  • 2. Recent advances and current controversies in the management of DCIS of the breast.
    Sakorafas GH, Farley DR, Peros G.
    Cancer Treat Rev; 2008 Oct; 34(6):483-97. PubMed ID: 18490111
    [Abstract] [Full Text] [Related]

  • 3. Treatment of ductal carcinoma in situ of the breast: review of recent advances and future prospects.
    Mokbel K.
    Int J Fertil Womens Med; 2003 Oct; 48(5):217-25. PubMed ID: 14626378
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Histological markers that predict clinical recurrence in ductal carcinoma in situ of the breast: an Australian population-based study.
    Provenzano E, Hopper JL, Giles GG, Marr G, Venter DJ, Armes JE.
    Pathology; 2004 Jun; 36(3):221-9. PubMed ID: 15203725
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion.
    Hildenbrand R, Schaaf A.
    Int J Oncol; 2009 Jan; 34(1):15-23. PubMed ID: 19082473
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. 259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up.
    Di Saverio S, Catena F, Santini D, Ansaloni L, Fogacci T, Mignani S, Leone A, Gazzotti F, Gagliardi S, De Cataldis A, Taffurelli M.
    Breast Cancer Res Treat; 2008 Jun; 109(3):405-16. PubMed ID: 17687650
    [Abstract] [Full Text] [Related]

  • 11. Residual ductal carcinoma in situ in patients with complete eradication of invasive breast cancer after neoadjuvant chemotherapy does not adversely affect patient outcome.
    Mazouni C, Peintinger F, Wan-Kau S, Andre F, Gonzalez-Angulo AM, Symmans WF, Meric-Bernstam F, Valero V, Hortobagyi GN, Pusztai L.
    J Clin Oncol; 2007 Jul 01; 25(19):2650-5. PubMed ID: 17602071
    [Abstract] [Full Text] [Related]

  • 12. Outcomes for women with ductal carcinoma-in-situ and a positive sentinel node: a multi-institutional audit.
    Moore KH, Sweeney KJ, Wilson ME, Goldberg JI, Buchanan CL, Tan LK, Liberman L, Turner RR, Lagios MD, Cody Iii HS, Giuliano AE, Silverstein MJ, Van Zee KJ.
    Ann Surg Oncol; 2007 Oct 01; 14(10):2911-7. PubMed ID: 17597346
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Clinical outcome after selective treatment of patients diagnosed with ductal carcinoma in situ of the breast.
    Meijnen P, Oldenburg HS, Peterse JL, Bartelink H, Rutgers EJ.
    Ann Surg Oncol; 2008 Jan 01; 15(1):235-43. PubMed ID: 17987342
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The molecular journey from ductal carcinoma in situ to invasive breast cancer.
    Wiechmann L, Kuerer HM.
    Cancer; 2008 May 15; 112(10):2130-42. PubMed ID: 18383519
    [Abstract] [Full Text] [Related]

  • 20. The role of CXCR4 receptor expression in breast cancer: a large tissue microarray study.
    Salvucci O, Bouchard A, Baccarelli A, Deschênes J, Sauter G, Simon R, Bianchi R, Basik M.
    Breast Cancer Res Treat; 2006 Jun 15; 97(3):275-83. PubMed ID: 16344916
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.